-
1
-
-
0030954732
-
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's Disease
-
DOI 10.1056/NEJM199710093371502
-
Targan SR, Hanauer SB, van Deventer SJH, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997;337:1029-1035. (Pubitemid 27430520)
-
(1997)
New England Journal of Medicine
, vol.337
, Issue.15
, pp. 1029-1035
-
-
Targan, S.R.1
Hanauer, S.B.2
Van Deventer, S.J.H.3
Mayer, L.4
Present, D.H.5
Braakman, T.6
DeWoody, K.L.7
Schaible, T.F.8
Rutgeerts, P.J.9
-
2
-
-
43549094970
-
Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease
-
Hanai H, Iida T, Takeuchi K, Watanabe F, Yamada M, Kikuyama M, Maruyama Y, Iwaoka Y, Hirayama K, Nagata S, Takai K. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Am J Gastroenterol 2008;103:1210-1216.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 1210-1216
-
-
Hanai, H.1
Iida, T.2
Takeuchi, K.3
Watanabe, F.4
Yamada, M.5
Kikuyama, M.6
Maruyama, Y.7
Iwaoka, Y.8
Hirayama, K.9
Nagata, S.10
Takai, K.11
-
3
-
-
19944429890
-
Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: An open multicenter prospective study
-
DOI 10.1007/s00535-004-1465-z
-
Fukuda Y, Matsui T, Suzuki Y, Kanke K, Matsumoto T, Takazoe M, Matsumoto T, Motoya S, Honma T, Sawada K, Yao T, Shimoyama T, Hibi T. Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study. J Gastroenterol 2004;39:1158-1164. (Pubitemid 40074281)
-
(2004)
Journal of Gastroenterology
, vol.39
, Issue.12
, pp. 1158-1164
-
-
Fukuda, Y.1
Matsui, T.2
Suzuki, Y.3
Kanke, K.4
Matsumoto, T.5
Takazoe, M.6
Matsumoto, T.7
Motoya, S.8
Honma, T.9
Sawada, K.10
Yao, T.11
Shimoyama, T.12
Hibi, T.13
-
4
-
-
0018292706
-
National cooperative Crohn's disease study: Study design and conduct of the study
-
Winship DH, Summers RW, Singleton JW, Best WR, Becktel JM, Lenk LF, Kern F Jr. National cooperative Crohn s disease study: study design and conduct of the study. Gastroenterology 1979;77:829-842. (Pubitemid 9257851)
-
(1979)
Gastroenterology
, vol.77
, Issue.4 II
, pp. 829-842
-
-
Winship, D.H.1
Summers, R.W.2
Singleton, J.W.3
-
5
-
-
0029775580
-
The Short Inflammatory Bowel Disease Questionnaire: A quality of life instrument for community physicians managing inflammatory bowel disease
-
CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial
-
Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 1996;91:1571-1578.
-
(1996)
Am J Gastroenterol
, vol.91
, pp. 1571-1578
-
-
Irvine, E.J.1
Zhou, Q.2
Thompson, A.K.3
-
6
-
-
0037379792
-
Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial
-
DOI 10.1053/gast.2003.50145
-
Farrel RJ, Alsahli M, Jeen YT, Falchuk KR, Peppercorn MA, Michetti P. Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn s disease: a randomized controlled trial. Gastroenterology 2003;124:917-924. (Pubitemid 36389794)
-
(2003)
Gastroenterology
, vol.124
, Issue.4
, pp. 917-924
-
-
Farrell, R.J.1
Alsahli, M.2
Jeen, Y.-T.3
Falchuk, K.R.4
Peppercorn, M.A.5
Michetti, P.6
-
7
-
-
78751483298
-
-
FDA news release, 4 August available at: Accessed October 22nd, 2009
-
Cancer Warnings Required for TNF Blockers. FDA news release, The U.S. Food and Drug Administration, 4 August 2009, available at: http://www.fda.gov/ NewsEvents/Newsroom/PressAnnouncements/ucm175803.htm Accessed October 22nd, 2009.
-
(2009)
Cancer Warnings Required for TNF Blockers
-
-
-
8
-
-
0033528272
-
Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease
-
DOI 10.1016/S0140-6736(98)03339-X
-
Schreiber S, Nikolaus S, Hampe J. Tumour necrosis factor alpha and interleukin 1beta in relapse of Crohn's disease. Lancet 1999;353:459-461. (Pubitemid 29067338)
-
(1999)
Lancet
, vol.353
, Issue.9151
, pp. 459-461
-
-
Schreiber, S.1
Nikolaus, S.2
Hampe, J.3
Hamling, J.4
Koop, I.5
Groessner, B.6
Lochs, H.7
Raedler, A.8
-
9
-
-
0031903013
-
Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation
-
Nikolaus S, Bauditz J, Gionchetti P. Increased secretion of proinflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin-10 during intestinal inflammation. Gut 1998;42:470-476. (Pubitemid 28186561)
-
(1998)
Gut
, vol.42
, Issue.4
, pp. 470-476
-
-
Nikolaus, S.1
Bauditz, J.2
Gionchetti, P.3
Witt, C.4
Lochs, H.5
Schreiber, S.6
-
10
-
-
0031835846
-
A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis
-
Kashiwagi N, Hirata I, Kasukawa R. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher 1998;2:134-141. (Pubitemid 28311172)
-
(1998)
Therapeutic Apheresis
, vol.2
, Issue.2
, pp. 134-141
-
-
Kashiwagi, N.1
Hirata, I.2
Kasukawa, R.3
-
11
-
-
67649643627
-
Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: Clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan
-
Hibi T, Sameshima Y, Sekiguchi Y, Hisatome Y, Maruyama F, Moriwaki K, Shima C, Saniabadi AR, Matsumoto T. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan. Dig Liver Dis 2009;41:570-577.
-
(2009)
Dig Liver Dis
, vol.41
, pp. 570-577
-
-
Hibi, T.1
Sameshima, Y.2
Sekiguchi, Y.3
Hisatome, Y.4
Maruyama, F.5
Moriwaki, K.6
Shima, C.7
Saniabadi, A.R.8
Matsumoto, T.9
|